30
Participants
Start Date
May 18, 2022
Primary Completion Date
April 11, 2024
Study Completion Date
May 11, 2024
Nonacog beta pegol
Nonacog beta pegol is administered as intravenous injections. Participants will receive nonacog beta pegol as prophylaxis, as on-demand for treatment of bleeding episodes and in relation to surgery.
Beijing Children's Hospital，Capital Medical University, Beijing
Peking Union Medical College Hospital, Beijing
The First Affiliated Hospital of Soochow University, Suzhou
Jinan Central Hospital, Ji'nan
The Affiliated Hospital of Qingdao University, Qingdao
Institute of hematology and Blood Diseases Hospital, Tianjin-Hematology, Tianjin
Children's Hospital, Zhejiang University school of medicine, Hangzhou
Fujian Medical University Union Hospital-Hematology, Fuzhou
Xiangya Hospital Central-South University, Changsha
Tongji Hospital, Tongji Medical College of HUST-Hematology, Wuhan
Henan Cancer Hospital-Hematology, Zhengzhou
Haemotology, Nanfang Hospital, Southern Medical University, Guangzhou
The Affiliated hospital of Guizhou Medical University-Hemato, Guiyang
The Second Affiliated Hospital of Kunming Medical University, Kunming
Lead Sponsor
Novo Nordisk A/S
INDUSTRY